August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
August 20, 2024 C-Path’s RDCA-DAP Announces Strategic Partnership with Vivli to Enhance Clinical Trials Data Sharing for Rare Diseases C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...
August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler...
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS C-Path)'sTranslational Therapeutics Accelerator (TRxA) announced today a new research grant awarded...
August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
July 26, 2024 C-Path’s Alzheimer’s Consortium Unveils Seminal Methodology to Enhance Alzheimer’s Clinical Trials Using Imaging Biomarkers C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...
July 23, 2024 DATAcc by DiMe Expands Library of Digital Measurement Products to Include Parkinson’s Disease Today, the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe), in partnership....
July 23, 2024 C-Path’s Lysosomal Disease Consortium Welcomes Chiesi Group as its Newest Member C-Path's Critical Path for Lysosomal Diseases (CPLD) Consortium today proudly announced the addition of Chiesi Group...
July 1, 2024 Lane United Football Club’s ‘United Against Cancer’ Game to Support Sarcoma Community The event, scheduled for Wed., July 3, is supported by C-Path's CDRC, xCures and hummel as sponsors.
June 20, 2024 C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...